Answers are grounded in this paper and cite their sources.
Transcranial temporal interference stimulation (tTIS) is an emerging non-invasive neuromodulation technique that enables targeted stimulation of deep brain regions. This study evaluated the efficacy and neurophysiological effects of cerebellar dentate nucleus (DN)-targeted tTIS for enhancing short-term upper extremity motor function improvement in subacute stroke. In this double-blind, sham-controlled randomized trial, 50 subacute stroke patients (of 72 screened) were allocated 1:1 to receive 10 sessions of active DN-tTIS ( n = 25) or sham stimulation ( n = 25), both combined with standardized conventional upper-extremity rehabilitation. Primary outcomes were changes in Fugl-Meyer Assessment Upper Extremity (FMA-UE) total score and Action Research Arm Test (ARAT). Secondary behavioral outcomes included FMA-UE proximal and distal subscores. Resting-state EEG spectral power was analyzed as the main neurophysiological outcome, while functional connectivity, graph-theoretical metrics, and microstate dynamics were analyzed as exploratory outcomes. Forty-seven participants completed the clinical protocol (active, n = 23; sham, n = 24), corresponding to a retention rate of 94%. Groups were balanced at baseline, and blinding assessment suggested comparable treatment-guessing performance between groups. Active DN-tTIS yielded significant improvements versus sham on FMA-UE (adjusted mean difference 3.98 points, 95% CI 1.23–6.72, Cohen’s d = 0.85, p = 0.006) and ARAT (adjusted mean difference 2.98 points, 95% CI 1.23–4.73, d = 1.01, p = 0.005). Gains were driven predominantly by distal motor control (d = 2.46, p < 0.001), with proximal effects non-significant ( p = 0.179). Clinically meaningful ARAT improvement (MCID ≥ 5.7 points) occurred in 52.2% of active versus 8.7% of sham participants (OR = 15.62, p = 0.005). Exploratory interaction analyses did not identify significant interactions with lesion location or baseline severity. Resting-state EEG showed significant active-group increases in global beta power (q = 0.019) and ipsilateral frontal theta power (q = 0.027), without significant changes in functional connectivity or network topology. Microstate analysis revealed intervention-specific reductions in Class D duration and increased Class C occurrence in the active group. No serious adverse events occurred. DN-targeted tTIS was safe and feasible, producing short-term improvements in upper-extremity motor function, particularly distal wrist and hand control, when combined with conventional rehabilitation in subacute stroke. Accompanying EEG changes in oscillatory power and exploratory microstate dynamics provide an initial physiological characterization of DN-tTIS effects, but their relationship to individual treatment response and long-term clinical benefit requires further validation. The study was registered in the Chinese Clinical Trial Registry (ID: ChiCTR2500107031) on July 28, 2025. The registration was submitted on August 1, 2025. The first participant enrolled on August 4, 2025.
No takes yet. Share an insight, caveat, or question.
Yasen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: